Vivos Inc. (OTCMKTS:RDGL – Get Free Report) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 59,400 shares, a decline of 42.9% from the March 31st total of 104,000 shares. Based on an average trading volume of 3,214,800 shares, the days-to-cover ratio is presently 0.0 days.
Vivos Trading Up 25.1 %
RDGL stock traded up $0.03 during midday trading on Friday, reaching $0.15. 2,763,974 shares of the company’s stock traded hands, compared to its average volume of 759,674. Vivos has a 52 week low of $0.04 and a 52 week high of $0.16. The company has a 50-day moving average price of $0.08 and a two-hundred day moving average price of $0.07.
Vivos (OTCMKTS:RDGL – Get Free Report) last issued its earnings results on Monday, March 18th. The company reported ($0.01) earnings per share (EPS) for the quarter.
About Vivos
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Recommended Stories
- Five stocks we like better than Vivos
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Stocks Leading the U.S. Agriculture Comeback
- How to buy stock: A step-by-step guide for beginners
- How to Use Put Debit Spreads to Profit From Falling Stocks
- The How and Why of Investing in Gold Stocks
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Vivos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos and related companies with MarketBeat.com's FREE daily email newsletter.
